Close Menu

NEW YORK – University of Oxford researchers are developing a molecular diagnostic test for COVID-19 that provides results within 30 minutes and holds potential for future at-home use.  

The test, which recognizes SARS-CoV-2 RNA and RNA fragments, could be ready in a few weeks for global regulatory authorities to assess whether it can be used in clinical practice to detect the SARS-CoV-2 coronavirus, Zhanfeng Cui, one of the test's developers, said in an interview.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

An analysis of blood donations suggests SARS-CoV-2 was present in the US weeks earlier than thought, according to NPR.

The Guardian reports that DeepMind Technologies' AlphaFold can predict how proteins fold.

CNBC reports that a US Centers for Disease Control and Prevention advisory panel is to vote on how to distribute COVID-19 vaccines.

In PNAS this week: targeting progesterone signaling in ovarian cancer, LINE-1 retrotransposition events in adenocarcinomas, and more.

Dec
03
Sponsored by
Mission Bio

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion.